Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
Open Access
- 29 June 2022
- journal article
- research article
- Published by Springer Nature in npj Precision Oncology
- Vol. 6 (1) , 1-8
Abstract
Hormone receptor expression is a characteristic of low-grade serous ovarian carcinoma (LGSOC). Studies investigating estrogen receptor (ER) and progesterone receptor (PR) expression levels suggest its prognostic and predictive significance, although their associations with key molecular aberrations are not well understood. As such, we sought to describe the specific genomic profiles associated with different ER/PR expression patterns and survival outcomes in a cohort of patients with advanced disease. The study comprised fifty-five advanced-staged (III/IV) LGSOCs from the Canadian Ovarian Experimental Unified Resource (COEUR) for which targeted mutation sequencing, copy-number aberration, clinical and follow-up data were available. ER, PR, and p16 expression were assessed by immunohistochemistry. Tumors were divided into low and high ER/PR expression groups based on Allred scoring. Copy number analysis revealed that PR-low tumors (Allred score p = 0.001), with cancer genes affected within specific loci linked to altered peptidyl-tyrosine kinase, MAP-kinase, and PI3-kinase signaling. Cox regression analysis showed that ER-high (p = 0.02), PR-high (p = 0.03), stage III disease (p = 0.02), low residual disease burden (p = 0.01) and normal p16 expression (p<0.001) were all significantly associated with improved overall survival. This study provides evidence that genomic aberrations are linked to ER/PR expression in primary LGSOC.Keywords
This publication has 41 references indexed in Scilit:
- Specimen Quality Evaluation in Canadian Biobanks Participating in the COEUR RepositoryBiopreservation and Biobanking, 2013
- Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancerBritish Journal of Cancer, 2012
- CDK2-dependent activation of PARP-1 is required for hormonal gene regulation in breast cancer cellsGenes & Development, 2012
- Low‐grade serous carcinomas of the ovary contain very few point mutationsThe Journal of Pathology, 2011
- Clinicodemographic factors influencing outcomes in patients with low-grade serous ovarian carcinomaCancer, 2011
- Application of Nexus Copy Number Software for CNV Detection and AnalysisCurrent Protocols in Human Genetics, 2010
- ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium StudyCancer Epidemiology, Biomarkers & Prevention, 2010
- BioGRID: a general repository for interaction datasetsNucleic Acids Research, 2006
- Association of the Ku autoantigen/DNA-dependent protein kinase holoenzyme and poly(ADP-ribose) polymerase with the DNA binding domain of progesterone receptorsJournal of Molecular Endocrinology, 2000
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994